#1 Clinical Trials Search in Europe

Colesevelam

Colesevelam, a bile acid sequestrant, has been the subject of numerous clinical trials investigating its effects on various medical conditions. Originally approved for lowering cholesterol, recent studies have explored its potential benefits in managing diabetes, irritable bowel syndrome, and other metabolic disorders. This article summarizes key findings from clinical trials using Colesevelam and its impact on patient health.

Table of Contents

What is Colesevelam?

Colesevelam, also known by its brand names Welchol, Lodalis, or Cholestagel, is a medication primarily used to lower cholesterol levels and improve blood sugar control in certain patients[1][2]. It belongs to a class of drugs called bile acid sequestrants, which work by binding to bile acids in the intestine[3].

Conditions Treated by Colesevelam

Colesevelam is approved for use in several medical conditions:

  • High Cholesterol: It helps lower low-density lipoprotein (LDL) cholesterol, often referred to as “bad” cholesterol[4].
  • Type 2 Diabetes: Colesevelam can help improve blood sugar control in adults with type 2 diabetes[2].
  • Diarrhea-predominant Irritable Bowel Syndrome (IBS-D): Some studies have investigated its use in managing symptoms of IBS-D[1].

How Colesevelam Works

Colesevelam works through several mechanisms:

  1. Bile Acid Binding: It binds to bile acids in the intestine, preventing their reabsorption. This leads to the body using more cholesterol to produce new bile acids, thereby lowering blood cholesterol levels[3].
  2. Glucose Control: While not fully understood, colesevelam appears to improve blood sugar control in people with type 2 diabetes. This may be related to its effects on bile acids and their role in glucose metabolism[3].
  3. Intestinal Effects: In IBS-D, colesevelam may help by binding bile acids that can cause diarrhea[1].

Dosage and Administration

Colesevelam is available in two forms:

  • Tablets: Typically prescribed as 3.75 grams daily, often divided into two doses of 3 tablets each (625 mg per tablet)[4].
  • Oral Suspension: A powder form that can be mixed with water or other liquids, particularly useful for children or those who have difficulty swallowing tablets[5].

The medication is usually taken with meals to maximize its effectiveness[2].

Effectiveness of Colesevelam

Research has shown that colesevelam can be effective in:

  • Lowering LDL cholesterol by approximately 15-18%[4].
  • Reducing hemoglobin A1c (a measure of long-term blood sugar control) by about 0.5% in people with type 2 diabetes[2].
  • Potentially improving symptoms in some patients with IBS-D, though more research is needed[1].

Potential Side Effects

While generally well-tolerated, colesevelam may cause some side effects, including:

  • Constipation
  • Nausea
  • Bloating
  • Increased triglycerides (a type of fat in the blood)

It’s important to discuss any side effects with your healthcare provider[6].

Ongoing Research

Researchers continue to study colesevelam for potential use in other conditions:

  • Type 1 Diabetes: Studies are investigating if colesevelam can help improve blood sugar control in people with type 1 diabetes[4].
  • Nonalcoholic Steatohepatitis (NASH): This is a severe form of fatty liver disease. Research is exploring whether colesevelam could help reduce liver fat in patients with NASH[7].
  • Pediatric Type 2 Diabetes: Studies are evaluating the safety and effectiveness of colesevelam in children and adolescents with type 2 diabetes[5].
Condition Key Findings Dosage Duration
Type 2 Diabetes Improved glycemic control, reduced HbA1c and fasting plasma glucose 3.75 g daily 12-24 weeks
IBS with Diarrhea Potential to decrease colonic transit and improve bowel function 1.875 g twice daily 12-14 days
Hyperlipidemia Lowered LDL cholesterol levels 3.75 g daily 12-24 weeks
Pediatric Type 2 Diabetes Safety and efficacy being evaluated 3.75 g or 0.625 g daily 6-12 months
Prediabetes Potential improvement in insulin sensitivity and β-cell function 3.75 g daily 8 weeks

FAQ

  • What is Colesevelam and how does it work? Colesevelam is a bile acid sequestrant that binds to bile acids in the intestine, preventing their reabsorption. This leads to increased conversion of cholesterol to bile acids in the liver, which can help lower cholesterol levels. It may also have effects on glucose metabolism, though the exact mechanism is not fully understood.
  • What conditions has Colesevelam been studied for in clinical trials? Clinical trials have investigated Colesevelam for various conditions, including type 2 diabetes, irritable bowel syndrome with diarrhea (IBS-D), hyperlipidemia, and impaired glucose tolerance. Some studies have also looked at its effects in type 1 diabetes and prediabetes.
  • How effective is Colesevelam in managing diabetes? Several studies have shown that Colesevelam can improve glycemic control in patients with type 2 diabetes. It has been found to lower HbA1c levels and fasting plasma glucose. However, its effectiveness may vary among individuals, and it is often used as an add-on therapy to other diabetes medications.
  • Are there any side effects associated with Colesevelam use? Common side effects of Colesevelam may include constipation, nausea, and abdominal pain. In some studies, it was generally well-tolerated. However, as with any medication, individual responses may vary, and patients should discuss potential side effects with their healthcare provider.
  • Can Colesevelam be used in children with diabetes? Some clinical trials have investigated the use of Colesevelam in children with type 2 diabetes. These studies aimed to evaluate its safety, tolerability, and efficacy in improving blood sugar control in pediatric patients aged 10-17 years. However, more research may be needed to establish its long-term effects in this population.

Ongoing Clinical Trials on Colesevelam

  • Study on Switching from Dulaglutide to Tirzepatide for Adults with Type 2 Diabetes

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    Belgium France Germany Romania

Glossary

  • Bile acid sequestrant: A type of medication that binds to bile acids in the intestine, preventing their reabsorption and leading to increased excretion of cholesterol from the body.
  • HbA1c: Glycated hemoglobin, a measure of average blood sugar levels over the past 2-3 months, used to diagnose and monitor diabetes.
  • LDL cholesterol: Low-density lipoprotein cholesterol, often referred to as 'bad' cholesterol, which can contribute to the buildup of plaque in arteries.
  • Irritable Bowel Syndrome (IBS): A common digestive disorder characterized by abdominal pain, bloating, and changes in bowel habits.
  • Fasting plasma glucose: The level of glucose in the blood after an 8-12 hour fast, used to diagnose and monitor diabetes.
  • Hyperlipidemia: A condition characterized by elevated levels of lipids (fats) in the blood, including cholesterol and triglycerides.
  • Prediabetes: A condition where blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes.
  • Continuous glucose monitoring (CGM): A method for tracking glucose levels throughout the day and night using a sensor inserted under the skin.
  • Insulin sensitivity: The body's responsiveness to insulin, which affects how efficiently glucose is taken up by cells.
  • Incretin hormones: Hormones produced in the gut that stimulate insulin secretion in response to food intake.

References

  1. https://clinicaltrials.gov/study/NCT00911612
  2. https://clinicaltrials.gov/study/NCT00993824
  3. https://clinicaltrials.gov/study/NCT00596427
  4. https://clinicaltrials.gov/study/NCT00938405
  5. https://clinicaltrials.gov/study/NCT01258075
  6. https://clinicaltrials.gov/study/NCT02682680
  7. https://clinicaltrials.gov/study/NCT01066364